[LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms]

Urologe A. 2019 Jul;58(7):795-798. doi: 10.1007/s00120-019-0955-9.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adrenergic alpha-1 Receptor Antagonists / therapeutic use*
  • Humans
  • Indoles / therapeutic use*
  • Lower Urinary Tract Symptoms / drug therapy*
  • Lower Urinary Tract Symptoms / etiology
  • Male
  • Naphthalenes / therapeutic use*
  • Piperazines / therapeutic use*
  • Prostatic Hyperplasia / complications
  • Prostatic Hyperplasia / drug therapy*
  • Quinazolines / therapeutic use*
  • Tamsulosin / therapeutic use*
  • Treatment Outcome
  • Urological Agents / therapeutic use*

Substances

  • Adrenergic alpha-1 Receptor Antagonists
  • Indoles
  • Naphthalenes
  • Piperazines
  • Quinazolines
  • Urological Agents
  • alfuzosin
  • silodosin
  • Tamsulosin
  • naftopidil